Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for SRx Health Solutions (SRXH) over the last 14 years, with Q2 2025 value amounting to $690000.0.

  • SRx Health Solutions' Net Cash Flow rose 201666.67% to $690000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$634000.0, marking a year-over-year decrease of 14255.03%. This contributed to the annual value of -$5.0 million for FY2023, which is 7422.57% up from last year.
  • Latest data reveals that SRx Health Solutions reported Net Cash Flow of $690000.0 as of Q2 2025, which was up 201666.67% from -$1.9 million recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Net Cash Flow peaked at $30.7 million during Q3 2021, and registered a low of -$5.6 million during Q2 2022.
  • Over the past 5 years, SRx Health Solutions' median Net Cash Flow value was -$1.1 million (recorded in 2023), while the average stood at $37055.6.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 228449.5% in 2021, then crashed by 158494.62% in 2022.
  • SRx Health Solutions' Net Cash Flow (Quarter) stood at -$4.3 million in 2021, then grew by 27.25% to -$3.1 million in 2022, then soared by 120.85% to $655000.0 in 2023, then dropped by 7.63% to $605000.0 in 2024, then rose by 14.05% to $690000.0 in 2025.
  • Its last three reported values are $690000.0 in Q2 2025, -$1.9 million for Q1 2025, and $605000.0 during Q4 2024.